(last updated 20250124 07:36 e.s.t.)
INVEGA Main
 || Go to photographs 0061-0120 || Go to 2016 and 2007 product monographs for Toronto, Ontario’s Teva Canada Limited’s Haloperidol at s.11.120-11.137 and Boucherville, Quebec’s Sandoz Canada Inc.’s Risperidone at 11.138-148 linked to https://twb.rocks/upig/psych/population-control , respectively.

Andee Jak’s questions for Johnson & Johnson (“J&J”) during its 20250122, 75-minute analyst call (that she didn’t get to ask … while calling from Niagara Health’s fully-surveilled St. Catharines Hospital’s … psych ward).

(Work-in-progress) testimony of her 21-day on-ward experience is viewable at https://twb.rocks/organized-crime/vis/victor-uwaifo

202x updated product monographs that I had to request from the company myself (insert links)


2017 INVEGA (tablets) Product Monograph

Part I: Health Professional Information

1.001

1.002

1.003

1.004

1.005

1.006

1.007

1.008

1.009

1.010

1.011

1.012

1.013

1.014

1.015

1.016

1.017

1.018

1.019

1.020

1.021

1.022

1.023

1.024

1.025

1.026

1.027

1.028

1.029

1.030

1.031

1.032

1.033

Part II: Scientific Information (LOL (ie. Laugh Out Loud))

1.034

1.035

1.036

1.037

1.038

1.039

1.040

Part III: Consumer Information

1.041

1.042

1.043

1.044

1.045


CAMH Overview (ie. the “UN-authored”, UN-dated, UN-sourced document that Dr. Victor Uwaifo initially handed to me in order to “assess [my] understanding of antipsychotics”. (LOL)

Then, he handed to me the stale-dated, 45-page document produced by J&J’s Janssen Inc. posted above.

2.001 to 2.014 not yet uploaded as of 20250124 07:17 e.s.t

2.003

2.004

2.005

2.006

2007

2.008

2.009

22-Sep-24   7.001

7.002

7.003

7.004

7.005

7.006

7.007

HSC Main || Go to pages 0061-0120

(sections 7.008-8.014)